TrademarkDir
CORSHE
DEAD

Serial Number

97236120

Owner

Bioved Pharmaceuticals, Inc.

Attorney

Mark Farrell

First Use Date

Aug 26, 2020

Filing Date

Jan 24, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CORSHE Trademark

Serial Number: 97236120

CORSHE is a trademark filed by Bioved Pharmaceuticals, Inc. on January 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Bioved Pharmaceuticals, Inc. (15 trademarks)

San Jose, CA 95131

Entity Type: 03

Trademark Details

Filing Date

January 24, 2022

Registration Date

Not Registered

First Use Anywhere

August 26, 2020

First Use in Commerce

June 25, 2021

Published for Opposition

May 3, 2022

Goods & Services

Cough drops; Cough expectorants; Cough lozenges; Cough pastilles for medical use; Cough syrups; Cough syrups for medical use; Cough treatment preparations; Herbal extracts for medical purposes; Herbal honey throat lozenges; Herbal supplements; Herbal supplements for the treatment and relief of cough and other respiratory symptoms associated with a wide variety of acute and chronic disorders, consisting of a synergistic combination of plants in liquid, lozenge, tablet, or capsule form for oral administration, or in topical form; Anti-cough drops; Anti-tussive expectorants; Liquid herbal supplements; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Natural herbal supplements

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 6, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 6, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 6, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 15, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 23, 2023 SUPC
USE AMENDMENT FILED
Jun 19, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 19, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 23, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 22, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 21, 2023 AITU
NOTICE OF REVIVAL - E-MAILED
Jan 31, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 30, 2023 TPEX
PETITION TO REVIVE-GRANTED
Jan 30, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 30, 2023 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 30, 2023 ABN6
SOU EXTENSION 1 FILED
Dec 28, 2022 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 26, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2022 NWOS
NEW APPLICATION ENTERED
Jan 27, 2022 NWAP

Related Trademarks

More from this Owner

BIOVED PHARMACEUTICALS, INC. logo

BIOVED PHARMACEUTICALS, INC.

BIOVED PHARMACEUTICALS, INC. logo

BIOVED PHARMACEUTICALS, INC.

BIOVED PHARMACEUTICALS, INC. logo

BIOVED PHARMACEUTICALS, INC.

ANILIVE

ANILIVE

ANILIVE

ANILIVE

AMMUNEX

AMMUNEX